Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyaluronidase as an Adjuvant to Bupivacaine in Supraclavicular Brachial Plexus Block
NCT05083663Phase 3Unknown
- Sponsor
- Sohag University
- Start
- Sep 2021
- Primary completion
- Nov 2021
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hyaluronidase in postoperative pain (2 arms), sponsored by Sohag University. Primary endpoints: Onset of complete sensory block at 24 hours and Onset of complete motor block at 24 hours. Status: unknown.
02
Drugs
hyaluronidase
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05083663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083663.